PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 2564008-14 1989 The residual PRL responses were negatively correlated with free triiodothyronine levels and positively with serotonergic variables, i.e., 5-hydroxyindoleacetic acid in 24-h urine and the ratio L-tryptophan/competing amino acids. Triiodothyronine 64-80 prolactin Homo sapiens 13-16 409288-4 1977 After treatment with triiodothyronine (T3), the elevated TSH and PRL levels fell to within normal ranges, and the galactorrhea disappeared. Triiodothyronine 21-37 prolactin Homo sapiens 65-68 3932176-8 1985 When tumor cells were pretreated with various concentrations of triiodothyronine (T3), the PRL release was inhibited by 50% with 5 X 10(-11) M T3 and by 80% with 10(-9) M T3. Triiodothyronine 64-80 prolactin Homo sapiens 91-94 3932176-8 1985 When tumor cells were pretreated with various concentrations of triiodothyronine (T3), the PRL release was inhibited by 50% with 5 X 10(-11) M T3 and by 80% with 10(-9) M T3. Triiodothyronine 82-84 prolactin Homo sapiens 91-94 3932176-8 1985 When tumor cells were pretreated with various concentrations of triiodothyronine (T3), the PRL release was inhibited by 50% with 5 X 10(-11) M T3 and by 80% with 10(-9) M T3. Triiodothyronine 143-145 prolactin Homo sapiens 91-94 3932176-8 1985 When tumor cells were pretreated with various concentrations of triiodothyronine (T3), the PRL release was inhibited by 50% with 5 X 10(-11) M T3 and by 80% with 10(-9) M T3. Triiodothyronine 143-145 prolactin Homo sapiens 91-94 6480809-10 1984 Pharmacological studies of TSH, TSH-alpha, and PRL release using thyroid hormones (T3), dopamine agonist (bromocriptine), TRH, and cholera toxin yielded the following results: 1) T3 after 3 days of incubation produced a dose-dependent inhibition of TSH, TSH-alpha, and PRL release. Triiodothyronine 83-85 prolactin Homo sapiens 47-50 6425749-6 1984 These findings suggest that the changes in serum triiodothyronine (T3) significantly influence the release of prolactin and thyroid-stimulating hormone in response to thyrotropin-releasing hormone during the periparturitional period. Triiodothyronine 49-65 prolactin Homo sapiens 110-119 6425749-6 1984 These findings suggest that the changes in serum triiodothyronine (T3) significantly influence the release of prolactin and thyroid-stimulating hormone in response to thyrotropin-releasing hormone during the periparturitional period. Triiodothyronine 67-69 prolactin Homo sapiens 110-119 7291145-3 1981 In patients with thyrotoxicosis, a remarkable increase in prolactin level, which correlated with triiodothyronine content, was observed. Triiodothyronine 97-113 prolactin Homo sapiens 58-67 401825-0 1977 Effect of triiodothyronine treatment on prolactin secretion in patients with amenorrhea-galactorrhea. Triiodothyronine 10-26 prolactin Homo sapiens 40-49 6280965-1 1982 Electrophoretic analysis of soluble proteins from pituitary cells pulse labeled with [35S]methionine demonstrated that 10 nM T3 inhibited PRL synthesis, but did not affect the synthesis of most other pituitary proteins. Triiodothyronine 125-127 prolactin Homo sapiens 138-141 118103-0 1979 Effect of triiodothyronine administration on the plasma TSH and prolactin responses to TRH in patients with hypothalamic-pituitary insufficiency. Triiodothyronine 10-26 prolactin Homo sapiens 64-73 118103-1 1979 A study was carried out in 10 patients with multiple pituitary hormone deficiencies to determine the response of thyroid-stimulating hormone (TSH) and prolactin (PRL) to thyrotropin-releasing hormone (TRH) and their suppressibility by treatment with triiodothyronine (T3) given at a dose of 60 microgram/day for 1 week. Triiodothyronine 250-266 prolactin Homo sapiens 151-160 118103-1 1979 A study was carried out in 10 patients with multiple pituitary hormone deficiencies to determine the response of thyroid-stimulating hormone (TSH) and prolactin (PRL) to thyrotropin-releasing hormone (TRH) and their suppressibility by treatment with triiodothyronine (T3) given at a dose of 60 microgram/day for 1 week. Triiodothyronine 250-266 prolactin Homo sapiens 162-165 118103-1 1979 A study was carried out in 10 patients with multiple pituitary hormone deficiencies to determine the response of thyroid-stimulating hormone (TSH) and prolactin (PRL) to thyrotropin-releasing hormone (TRH) and their suppressibility by treatment with triiodothyronine (T3) given at a dose of 60 microgram/day for 1 week. Triiodothyronine 268-270 prolactin Homo sapiens 151-160 118103-1 1979 A study was carried out in 10 patients with multiple pituitary hormone deficiencies to determine the response of thyroid-stimulating hormone (TSH) and prolactin (PRL) to thyrotropin-releasing hormone (TRH) and their suppressibility by treatment with triiodothyronine (T3) given at a dose of 60 microgram/day for 1 week. Triiodothyronine 268-270 prolactin Homo sapiens 162-165 409288-4 1977 After treatment with triiodothyronine (T3), the elevated TSH and PRL levels fell to within normal ranges, and the galactorrhea disappeared. Triiodothyronine 39-41 prolactin Homo sapiens 65-68 4199418-1 1973 The influence of serum triiodothyronine (T(3)) and thyroxine (T(4)) concentrations on the release of prolactin in man was studied by determining the prolactin response to synthetic thyrotropin-releasing hormone (TRH) in hypothyroid and hyperthyroid patients before and after correction of their serum thyroid hormone abnormalities. Triiodothyronine 23-39 prolactin Homo sapiens 101-110 4199418-1 1973 The influence of serum triiodothyronine (T(3)) and thyroxine (T(4)) concentrations on the release of prolactin in man was studied by determining the prolactin response to synthetic thyrotropin-releasing hormone (TRH) in hypothyroid and hyperthyroid patients before and after correction of their serum thyroid hormone abnormalities. Triiodothyronine 41-45 prolactin Homo sapiens 101-110 9152619-5 1997 There was a close association between the increment in serum PRL and of free triiodothyronine above the basal level after TRH administration. Triiodothyronine 77-93 prolactin Homo sapiens 61-64 10979048-3 1996 On the other hand, hyperinsulinaemia and disorders in GH, PRL and cortisol release were associated with lower levels of reverse triiodothyronine, gonadotropins, testosterone, 17-corticoids and SHBG and higher levels of triiodothyronine, estradiol, 17-hydroxycorticoids and IGF-I. Triiodothyronine 128-144 prolactin Homo sapiens 58-61 10979048-3 1996 On the other hand, hyperinsulinaemia and disorders in GH, PRL and cortisol release were associated with lower levels of reverse triiodothyronine, gonadotropins, testosterone, 17-corticoids and SHBG and higher levels of triiodothyronine, estradiol, 17-hydroxycorticoids and IGF-I. Triiodothyronine 219-235 prolactin Homo sapiens 58-61